While you may be more familiar with brand names such as Ozempic or Wegovy, these drugs are known as glucagon-like peptide-1 (GLP-1) agonists in the medical world. Eli Lilly ( LLY -0.50%) has emerged ...
GLP-1 receptor agonists, originally introduced in 2006, have undergone significant advancements over the years. David Ricks, ...
Eli Lilly's MounjaroNow, Eli Lilly, the largest pharmaceutical company in the world in terms of market capitalisation, has ...
With approximately 101 million individuals living with diabetes, increasing access to insulin and advanced treatments is ...
He also met with pharmaceutical firm Eli Lilly, medical device company Medtronic and specialty glass maker Corning, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback